MX2020006634A - Formulaciones de surfactantes para inhalacion. - Google Patents

Formulaciones de surfactantes para inhalacion.

Info

Publication number
MX2020006634A
MX2020006634A MX2020006634A MX2020006634A MX2020006634A MX 2020006634 A MX2020006634 A MX 2020006634A MX 2020006634 A MX2020006634 A MX 2020006634A MX 2020006634 A MX2020006634 A MX 2020006634A MX 2020006634 A MX2020006634 A MX 2020006634A
Authority
MX
Mexico
Prior art keywords
inhalation
surfactant formulations
respirable
polypeptide
formulated
Prior art date
Application number
MX2020006634A
Other languages
English (en)
Inventor
Michael M Lipp
Holly Chan
Original Assignee
Civitas Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Civitas Therapeutics Inc filed Critical Civitas Therapeutics Inc
Publication of MX2020006634A publication Critical patent/MX2020006634A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención está dirigida a formulaciones de partículas de polvo seco, respirables de surfactantes pulmonares que opcionalmente comprenden proteínas y/o polipéptidos surfactantes y que se formulan para el suministro al sistema pulmonar a través de la inhalación.
MX2020006634A 2017-12-21 2018-12-19 Formulaciones de surfactantes para inhalacion. MX2020006634A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762609277P 2017-12-21 2017-12-21
PCT/US2018/066435 WO2019126289A1 (en) 2017-12-21 2018-12-19 Surfactant formulations for inhalation

Publications (1)

Publication Number Publication Date
MX2020006634A true MX2020006634A (es) 2021-01-15

Family

ID=66995083

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020006634A MX2020006634A (es) 2017-12-21 2018-12-19 Formulaciones de surfactantes para inhalacion.

Country Status (7)

Country Link
US (1) US20210386664A1 (es)
EP (1) EP3727353A4 (es)
JP (2) JP7335263B2 (es)
AU (1) AU2018392461A1 (es)
CA (1) CA3085944A1 (es)
MX (1) MX2020006634A (es)
WO (1) WO2019126289A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020006633A (es) * 2017-12-21 2021-01-15 Civitas Therapeutics Inc Formulaciones de surfactantes para inhalacion.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ292186B6 (cs) 1996-01-24 2003-08-13 Altana Pharma Ag Způsob výroby práškového prostředku s obsahem plicní povrchově aktivní látky, práškový prostředek a jeho použití
WO1997035882A1 (en) * 1996-03-27 1997-10-02 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
JP2003507410A (ja) 1999-08-25 2003-02-25 アドバンスト インハレーション リサーチ，インコーポレイテッド 乾燥粉末製剤からの放出調節
US20030091509A1 (en) * 2000-02-11 2003-05-15 Haefner Dietrich Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
DK1455755T3 (da) * 2001-11-20 2013-07-15 Civitas Therapeutics Inc Forbedrede partikelsammensætning til levering i lunge
KR101036058B1 (ko) * 2002-04-25 2011-05-19 더 스크립스 리서치 인스티튜트 폐질환 증상의 치료 및 예방
DK1531794T3 (en) * 2002-06-28 2017-08-28 Civitas Therapeutics Inc INHALABLE EPINEPHRIN
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US8563683B2 (en) * 2006-07-20 2013-10-22 University Of Rochester Synthetic lung surfactant and use thereof
KR20090060348A (ko) * 2006-09-19 2009-06-11 디스커버리 래보래토리스, 인크. 폐 계면활성제 제제 및 점액 클리어런스 촉진 방법
US8614255B2 (en) 2007-08-21 2013-12-24 Civitas Therapeutics, Inc. Pulmonary pharmaceutical formulations
CN102049040A (zh) * 2009-10-30 2011-05-11 北京隆旗生物科技有限公司 人工表面活性物质混合液及其制备与应用
PL2723323T3 (pl) * 2012-03-28 2016-05-31 Discovery Lab Inc Liofilizacja syntetycznego liposomalnego surfaktantu płucnego
EP3474832A1 (en) * 2016-06-24 2019-05-01 Civitas Therapeutics, Inc. Surfactant formulations for inhalation

Also Published As

Publication number Publication date
JP2023144081A (ja) 2023-10-06
AU2018392461A1 (en) 2020-07-02
JP7335263B2 (ja) 2023-08-29
US20210386664A1 (en) 2021-12-16
EP3727353A1 (en) 2020-10-28
JP2021508734A (ja) 2021-03-11
WO2019126289A1 (en) 2019-06-27
EP3727353A4 (en) 2021-10-13
CA3085944A1 (en) 2019-06-27

Similar Documents

Publication Publication Date Title
TN2015000395A1 (en) Respirable agglomerates of porous carrier particles and micronized drug
PH12018500594A1 (en) Adeno-associated virus factor viii vectors, associated viral particles and therapeutic formulations comprising the same
MX2023012602A (es) Formulaciones tensoactivas para inhalacion.
MX354828B (es) Polvos secos de cationes metálicos monovalentes para inhalación.
PH12018500544A1 (en) Inhalable nicotine formulations, and methods of making and using thereof
MX2015013845A (es) Polvos secos de tiotropio.
NZ752353A (en) Antifungal dry powders
GEP20186865B (en) Dry powder inhaler and inhalation actuated mechanism thereof
MX2023011674A (es) Formulaciones de surfactantes para inhalacion.
PH12018502714A1 (en) Nicotine particles and compositions
MX2019010263A (es) Formulaciones de nicotina inhalables y metodos de fabricacion y uso de las mismas.
MX2021003773A (es) Composiciones farmacéuticas y métodos relacionados con los agentes terapéuticos óticos.
PH12017502380A1 (en) Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof
MX2019005102A (es) Poxvirus quimericos sinteticos.
MX2019008105A (es) Virus.
MX2020006634A (es) Formulaciones de surfactantes para inhalacion.
SG10201808249VA (en) Lyophilized factor ix formulations
MX2020002793A (es) Composiciones de microesferas de gas encapsulado en lipidos y metodos relacionados.
EP3400214C0 (en) DRY POWDER INHALATOR COMPOSITIONS OF 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES
MX2019013570A (es) Particulas portadoras novedosas para formulaciones de polvo seco para inhalacion.
MX2021005508A (es) Fórmulaciones y procesos de polinucleótido en polvo respirable para inhalación.
MX2017004633A (es) Formulaciones que contienen tiotropio, aminoacidos y acidos, y metodos de estas.
TR201712424A2 (tr) Kuru toz i̇nhalasyon bi̇leşi̇mleri̇
MX2019001854A (es) Formulacion farmaceutica estable que comprende una composicion de tensioactivo pulmonar reconstituido.
EA201390206A1 (ru) Составы для бычьего гранулоцитарного колониестимулирующего фактора и его вариантов